1
|
Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry.
|
Circulation
|
2010
|
2.53
|
2
|
Prevalence, characteristics, and prognosis role of type 1 ST elevation in the peripheral ECG leads in patients with Brugada syndrome.
|
Heart Rhythm
|
2013
|
1.44
|
3
|
Thioarsenates in sulfidic waters.
|
Environ Sci Technol
|
2005
|
0.91
|
4
|
Mapping and ablation of ventricular fibrillation.
|
Minerva Cardioangiol
|
2004
|
0.88
|
5
|
Multiresidue determination of pesticides in drinking and related waters by gas chromatography/mass spectrometry after solid-phase extraction: interlaboratory study.
|
J AOAC Int
|
2001
|
0.83
|
6
|
Competitive and hindering effects of natural organic matter on the adsorption of MTBE onto activated carbons and zeolites.
|
Environ Technol
|
2005
|
0.82
|
7
|
Antiviral activity of an extract derived from roots of Eleutherococcus senticosus.
|
Antiviral Res
|
2001
|
0.80
|
8
|
The synthesis of Rantes, G-CSF, IL-4, IL-5, IL-6, IL-12 and IL-13 in human whole-blood cultures is modulated by an extract from Eleutherococcus senticosus L. roots.
|
Phytother Res
|
2001
|
0.78
|
9
|
[The place of ablation in the treatment of atrial fibrillation: where are we and where are we going?].
|
Arch Mal Coeur Vaiss
|
2004
|
0.78
|
10
|
Development of a common priority list of pharmaceuticals relevant for the water cycle.
|
Water Sci Technol
|
2009
|
0.77
|
11
|
Prospective validation of phased array intracardiac echocardiography for the assessment of atrial mechanical function during catheter ablation of atrial fibrillation.
|
Heart
|
2006
|
0.76
|
12
|
Telemetric assessment of referred vaginal hyperalgesia and the effect of indomethacin in a rat model of endometriosis.
|
Front Pharmacol
|
2012
|
0.76
|
13
|
[Catheter ablation for atrial fibrillation].
|
Ann Cardiol Angeiol (Paris)
|
2009
|
0.75
|
14
|
[Mapping and ablation of malignant ventricular arrhythmias].
|
Arch Mal Coeur Vaiss
|
2005
|
0.75
|
15
|
[Identification of candidates for multisite pacing: results and presumed mechanisms of action after five years experience].
|
Arch Mal Coeur Vaiss
|
2006
|
0.75
|
16
|
Echocardiographic advances in atrial fibrillation and supraventricular arrhythmias.
|
Minerva Cardioangiol
|
2005
|
0.75
|
17
|
Polar nitrogen compounds and their behaviour in the drinking water treatment process.
|
Water Res
|
2001
|
0.75
|
18
|
Inter-laboratory exercise on steroid estrogens in aqueous samples.
|
Environ Pollut
|
2009
|
0.75
|